Donation by Mallinckrodt Pharmaceuticals Underscores Prevention of Drug Abuse, Raises Awareness of Importance of Safe Disposal
LAS VEGAS – December 1, 2016 – Southern Nevada families can access a safe and responsible drug disposal method, thanks to a donation of 60,000 drug deactivation pouches by Mallinckrodt Pharmaceuticals designed to help prevent the abuse and misuse of leftover or unwanted prescription medication. Pouches will be distributed free of charge through a partnership with The College of Pharmacy at Roseman University of Health Sciences.
“While today’s medications can help us heal and add quality to our lives, prescription opioids are too often misused and abused, and they can lead to addition and overdoses, devastating lives and hurting families in our communities,” said Nevada Senator Patricia Farley, I-Las Vegas. “Prevention can begin by destroying unused medications before they fall into the wrong hands.”
“The growing epidemic of prescription opioids abuse has been catastrophic for many in Nevada. Time and time again we uncover new cases of overdose and addiction, and learn the long lasting effects this epidemic has on a person, their family and our community,” said Assemblyman Nelson Araujo, D-Las Vegas. “As a state, we must do all we can prevent drug addiction – and that prevention starts at home.”
The pouches will be distributed at health fairs and drug abuse awareness and education events in Southern Nevada by Roseman University College of Pharmacy’s Student Alliance, Drug Abuse Awareness Team and the Hispanic outreach student organization Movimiento Estudiantil Roseman, with support from partner organizations in the community.
The user-friendly, pouch-based systems deactivate prescription drugs and render chemical compounds safe for landfills. After placing pills in the specially formulated pouch and adding regular tap water, it can be sealed and thrown away with the household trash. The pouches are completely biodegradable, providing an environmentally responsible way to deactivate and dispose of drugs.
“These medication deactivation pouches can be used in the home and at any time as a safe and convenient way to dispose of unwanted, expired or unused medication,” said Scott Stolte, PharmD, dean of the Roseman University College of Pharmacy. “The collaboration behind this initiative effort demonstrates what we can do together to combat the drug misuse epidemic. If each of the 60,000 pouches is used to dispose of the pills they can hold, there will be 2.7 million less prescription pills available to fall into the wrong hands.”
Nearly 68 percent of those who used prescription pain relievers non-medically in 2012-2013 got them from friends or relatives, according to the 2013 Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health.
The drug deactivation pouches were purchased and donated by Mallinckrodt Pharmaceuticals, a leading global specialty pharmaceutical company as part of the company’s nationwide 1-million pouch donation initiative to help combat the abuse of prescription pain medications.
“As a company focused on the health and well-being of our patients and communities, Mallinckrodt has long been a strong advocate of addressing the complex issues of opioid misuse and abuse that cause so much harm to families,“ said Mark Trudeau, Mallinckrodt President and Chief Executive Officer. “We share the concerns of people across the nation, and believe that providing patients with a safe and responsible way to dispose of unused medications is critical in this fight against prescription drug abuse. Mallinckrodt is committed to working with policy makers, community leaders, law enforcement and industry partners to ensure the responsible use of pain medication and prevent unused medications from ending up in the wrong hands.”
The initiative reinforces Mallinckrodt’s long-standing commitment to the safe and responsible use of medications and collaboration with community leaders who share its goal of building public awareness of the critical role of responsible drug disposal in the fight against prescription drug abuse.
About Mallinckrodt Pharmaceuticals
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies, as well as nuclear imaging products. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and hemostasis products; and central nervous system drugs. To learn more about Mallinckrodt, visit www.mallinckrodt.com and www.mallinckrodt.com/disposal.
The drug deactivation pouches are manufactured by Minneapolis-based Verde Technologies.
About Roseman University
Founded in Henderson, Nevada in 1999, Roseman University of Health Sciences is a non-profit, private institution of higher learning training the next generation of undergraduate and graduate level health care professionals that serve, collaborate and set new standards in their communities and within their professions. With campuses in Henderson, Summerlin and South Jordan, Utah, the University is comprised of the College of Dental Medicine, offering an Advanced Education in Orthodontics and Dentofacial Orthopedics/
MBA residency and Doctor of Dental Medicine program; College of Pharmacy, offering a Doctor of Pharmacy and Professional Continuing Education; College of Nursing, offering a Bachelor of Science in Nursing and Accelerated Bachelor of Science in Nursing; and an MBA program. Roseman University of Health Sciences will also offer a Doctor of Medicine through its College of Medicine, with the first incoming class starting in 2017. More than 3,000 Roseman graduates are caring for patients, conducting research, and engaged in public health and policy in Nevada, Utah and across the country. Roseman University is regionally accredited by the Northwest Commission on Colleges and Universities.